Literature DB >> 31108403

Natalizumab induced cutaneous sarcoidosis-like reaction.

R Durcan1, C Heffron2, B Sweeney3.   

Abstract

We present a case of a drug-induced sarcoidosis -like reaction (DISR) occurring following initiation of Natalizumab for multiple sclerosis. The reaction was purely cutaneous, and disappeared following drug withdrawal. We highlight this case to the practicing neurologists, with warning to be wary of a new rash on immunomodulatory therapies.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Year:  2019        PMID： 31108403     DOI： 10.1016/j.jneuroim.2019.04.015

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN： 0165-5728            Impact factor:   3.478


  3 in total

1.  Granulomatous Cutaneous Drug Eruptions: A Systematic Review.

Authors:  Nidhi Shah; Monica Shah; Aaron M Drucker; Neil H Shear; Michael Ziv; Roni P Dodiuk-Gad
Journal:  Am J Clin Dermatol       Date:  2021-01       Impact factor: 7.403

2.  Cutaneous Adverse Reactions Associated with Monoclonal Antibodies Treatment in Multiple Sclerosis: Case Reports and Short Literature Review.

Authors:  Carmen Adella Sirbu; Raluca Ivan; Titus Mihai Vasile; Lucian George Eftimie; Daniel Octavian Costache
Journal:  J Clin Med       Date:  2022-06-27       Impact factor: 4.964

3.  Sarcoidosis manifesting during treatment with secukinumab for psoriatic arthritis.

Authors:  Colm Kirby; Darragh Herlihy; Lindsey Clarke; Ronan Mullan
Journal:  BMJ Case Rep       Date:  2021-02-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.